The intramolecular allostery of GRB2 governing its interaction with SOS1 is modulated by phosphotyrosine ligands.


Journal

The Biochemical journal
ISSN: 1470-8728
Titre abrégé: Biochem J
Pays: England
ID NLM: 2984726R

Informations de publication

Date de publication:
30 07 2021
Historique:
received: 17 02 2021
revised: 01 07 2021
accepted: 07 07 2021
pubmed: 8 7 2021
medline: 30 11 2021
entrez: 7 7 2021
Statut: ppublish

Résumé

Growth factor receptor-bound protein 2 (GRB2) is a trivalent adaptor protein and a key element in signal transduction. It interacts via its flanking nSH3 and cSH3 domains with the proline-rich domain (PRD) of the RAS activator SOS1 and via its central SH2 domain with phosphorylated tyrosine residues of receptor tyrosine kinases (RTKs; e.g. HER2). The elucidation of structural organization and mechanistic insights into GRB2 interactions, however, remain challenging due to their inherent flexibility. This study represents an important advance in our mechanistic understanding of how GRB2 links RTKs to SOS1. Accordingly, it can be proposed that (1) HER2 pYP-bound SH2 potentiates GRB2 SH3 domain interactions with SOS1 (an allosteric mechanism); (2) the SH2 domain blocks cSH3, enabling nSH3 to bind SOS1 first before cSH3 follows (an avidity-based mechanism); and (3) the allosteric behavior of cSH3 to other domains appears to be unidirectional, although there is an allosteric effect between the SH2 and SH3 domains.

Identifiants

pubmed: 34232285
pii: 229218
doi: 10.1042/BCJ20210105
doi:

Substances chimiques

GRB2 Adaptor Protein 0
GRB2 protein, human 0
Ligands 0
SOS1 Protein 0
Phosphotyrosine 21820-51-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2793-2809

Informations de copyright

© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Auteurs

Neda S Kazemein Jasemi (NS)

Institute of Biochemistry and Molecular Biology II, Medical Faculty of the Heinrich-Heine University, 40225 Düsseldorf, Germany.

Christian Herrmann (C)

Department of Physical Chemistry I, Ruhr University Bochum, Bochum, Germany.

Eva Magdalena Estirado (E)

Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, PO Box 513, 5600MB Eindhoven, The Netherlands.

Lothar Gremer (L)

Institute of Physical Biology, Heinrich Heine University Düsseldorf, 40204 Düsseldorf, Germany.
Institute of Biological Information Processing, Structural Biochemistry (IBI-7), Forschungszentrum Jülich, 52425 Jülich, Germany.

Dieter Willbold (D)

Institute of Physical Biology, Heinrich Heine University Düsseldorf, 40204 Düsseldorf, Germany.
Institute of Biological Information Processing, Structural Biochemistry (IBI-7), Forschungszentrum Jülich, 52425 Jülich, Germany.

Luc Brunsveld (L)

Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, PO Box 513, 5600MB Eindhoven, The Netherlands.

Radovan Dvorsky (R)

Institute of Biochemistry and Molecular Biology II, Medical Faculty of the Heinrich-Heine University, 40225 Düsseldorf, Germany.

Mohammad R Ahmadian (MR)

Institute of Biochemistry and Molecular Biology II, Medical Faculty of the Heinrich-Heine University, 40225 Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH